◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

Sernova Biotherapeutics Inc

Financial Statements (IFRS) · Amounts in CAD
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line Item FY 2025Oct 31, 2025 FY 2024Oct 31, 2024 FY 2023Oct 31, 2023 FY 2022Oct 31, 2022 FY 2021Oct 31, 2021
Total Revenue 0.00 0.00 0.00 0.00 --
Operating Revenue 0.00 0.00 0.00 0.00 --
Selling General And Administration 7.5M 8.9M 8.4M 7.8M --
General And Administrative Expense 7.5M 8.9M 8.4M 7.8M --
Research And Development 7.5M 22.7M 32.0M 16.9M --
Depreciation And Amortization In Income Statement 20,690 34,092 31,302 30,807 --
Operating Expense 15.0M 31.7M 40.5M 24.8M --
Operating Income -15.0M -31.7M -40.5M -24.8M --
EBIT -15.0M -31.6M -39.0M -24.3M --
Interest Expense 754,813 586,858 32,075 118,002 --
Interest Expense Non Operating 754,813 586,858 32,075 118,002 --
Interest Income 25,634 388,391 1.5M 577,285 --
Interest Income Non Operating 25,634 388,391 1.5M 577,285 --
Net Interest Income -729,179 -198,467 1.5M 459,283 --
Other Income Expense 18,168 -322,926 35,926 -126,058 --
Special Income Charges 55,215 18,862 0.00 -- --
Gain On Sale Of Security -37,047 -341,788 35,926 -126,058 --
Pretax Income -15.7M -32.2M -39.0M -24.4M --
Tax Provision 9,431 7,000 0.00 -- --
Tax Effect Of Unusual Items 2,725 -48,439 0.00 0.00 --
Net Income From Continuing And Discontinued Operation -15.7M -32.2M -39.0M -24.4M --
Net Income From Continuing Operation Net Minority Interest -15.7M -32.2M -39.0M -24.4M --
Net Income Including Noncontrolling Interests -15.7M -32.2M -39.0M -24.4M --
Net Income Common Stockholders -15.7M -32.2M -39.0M -24.4M --
Net Income -15.7M -32.2M -39.0M -24.4M --
EBITDA -14.6M -31.1M -38.5M -23.9M --
Normalized EBITDA -14.7M -30.7M -38.6M -23.7M --
Reconciled Depreciation 342,591 540,280 445,551 439,998 --
Basic EPS -- -0.10 -0.13 -0.09 -0.03
Diluted EPS -- -0.10 -0.13 -0.09 -0.03
Basic Average Shares -- 307.0M 303.3M 273.6M 245.5M
Diluted Average Shares -- 307.0M 303.3M 273.6M 245.5M
Total Unusual Items 18,168 -322,926 35,926 -126,058 --
Total Unusual Items Excluding Goodwill 18,168 -322,926 35,926 -126,058 --
Tax Rate For Calcs 0.15 0.15 0.00 0.00 --
Normalized Income -15.8M -31.9M -39.0M -24.3M --
Depreciation Amortization Depletion Income Statement 20,690 34,092 31,302 30,807 --
Depreciation Income Statement 20,690 34,092 31,302 30,807 --
Diluted NI Availto Com Stockholders -15.7M -32.2M -39.0M -24.4M --
Gain On Sale Of Ppe 55,215 18,862 0.00 -- --
Insurance And Claims 506,444 687,831 652,792 651,393 --
Net Income Continuous Operations -15.7M -32.2M -39.0M -24.4M --
Net Non Operating Interest Income Expense -729,179 -198,467 1.5M 459,283 --
Other Gand A 2.1M 5.2M 3.2M 1.9M --
Salaries And Wages 4.9M 3.1M 4.6M 5.2M --
Total Expenses 15.0M 31.7M 40.5M 24.8M --
Line Item FY 2025Oct 31, 2025 FY 2024Oct 31, 2024 FY 2023Oct 31, 2023 FY 2022Oct 31, 2022 FY 2021Oct 31, 2021
Cash And Cash Equivalents 265,004 6.0M 8.7M 3.8M --
Cash Cash Equivalents And Short Term Investments 265,004 6.0M 19.8M 49.8M --
Cash Financial 265,004 6.0M 8.7M 3.8M --
Other Short Term Investments -- 0.00 11.1M 46.0M 0.00
Receivables 122,633 298,104 1.1M 1.1M --
Prepaid Assets -- -- 164,664 168,012 4,200
Other Current Assets 135,013 159,170 164,664 -- --
Current Assets 522,650 6.5M 21.0M 51.1M --
Gross PPE 212,535 1.4M 1.0M 1.1M --
Accumulated Depreciation -194,811 -600,312 -506,499 -398,043 --
Net PPE 17,724 833,931 507,442 653,701 --
Goodwill And Other Intangible Assets -- 0.00 316,719 516,752 716,785
Other Intangible Assets -- -- -- 516,752 716,785
Other Non Current Assets -- -- -- -- 388,341
Total Non Current Assets 241,584 1.1M 1.1M 1.4M --
Total Assets 764,234 7.5M 22.1M 52.5M --
Current Debt 3.7M -- -- -- --
Current Debt And Capital Lease Obligation 3.7M 101,456 136,123 139,856 --
Accounts Payable 5.2M 17.2M 6.9M 3.6M --
Payables 6.7M 18.2M 7.5M 3.9M --
Payables And Accrued Expenses 8.6M 19.9M 9.4M 4.6M --
Current Accrued Expenses 1.9M 1.7M 1.8M 700,512 --
Other Current Liabilities 3.7M -- -- -- --
Current Liabilities 24.8M 20.0M 9.6M 4.7M --
Long Term Debt 1.0M -- -- -- --
Long Term Debt And Capital Lease Obligation 1.0M 468,484 0.00 136,123 --
Long Term Capital Lease Obligation 0.00 468,484 0.00 136,123 --
Total Non Current Liabilities Net Minority Interest 1.0M 468,484 0.00 136,123 --
Total Liabilities Net Minority Interest 25.8M 20.5M 9.6M 4.9M --
Common Stock 118.7M 116.7M 111.0M 111.0M --
Capital Stock 118.7M 116.7M 111.0M 111.0M --
Additional Paid In Capital 21.8M 20.7M 19.7M 12.5M --
Retained Earnings -166.1M -150.4M -118.2M -79.2M --
Common Stock Equity -25.1M -13.0M 12.5M 47.6M --
Stockholders Equity -25.1M -13.0M 12.5M 47.6M --
Total Equity Gross Minority Interest -25.1M -13.0M 12.5M 47.6M --
Total Capitalization -24.0M -13.0M 12.5M 47.6M --
Net Tangible Assets -25.1M -13.0M 12.2M 47.1M --
Tangible Book Value -25.1M -13.0M 12.2M 47.1M --
Working Capital -24.3M -13.5M 11.4M 46.4M --
Invested Capital -20.3M -13.0M 12.5M 47.6M --
Total Debt 4.8M 569,940 136,123 275,979 --
Net Debt 4.5M -- -- -- --
Share Issued 332.9M 325.3M 303.3M 303.3M --
Ordinary Shares Number 332.9M 325.3M 303.3M 303.3M --
Accrued Interest Receivable -- 0.00 319,386 356,751 0.00
Capital Lease Obligations 0.00 569,940 136,123 275,979 --
Current Capital Lease Obligation 0.00 101,456 136,123 139,856 --
Current Deferred Liabilities 12.5M 0.00 95,013 0.00 --
Dueto Related Parties Current 1.5M 919,680 662,261 286,410 --
Machinery Furniture Equipment 212,535 321,990 321,990 229,811 --
Non Current Prepaid Assets 223,860 223,860 259,164 223,860 --
Other Current Borrowings 3.7M -- -- -- --
Other Equity Interest 537,142 34,421 -- 3.3M 3.7M
Other Properties -- 1.1M 691,951 821,933 645,550
Other Receivables 18,155 39,756 194,998 383,756 --
Taxes Receivable 104,478 258,348 538,607 406,035 --
Line Item FY 2025Oct 31, 2025 FY 2024Oct 31, 2024 FY 2023Oct 31, 2023 FY 2022Oct 31, 2022 FY 2021Oct 31, 2021
Operating Cash Flow -10.9M -18.9M -30.3M -14.4M --
Cash Flow From Continuing Operating Activities -10.9M -18.9M -30.3M -14.4M --
Depreciation And Amortization 342,591 540,280 445,551 439,998 --
Depreciation Amortization Depletion 342,591 540,280 445,551 439,998 --
Stock Based Compensation 2.3M 1.7M 3.9M 7.5M --
Deferred Tax -70,000 0.00 -- -- --
Deferred Income Tax -70,000 0.00 -- -- --
Change In Working Capital 1.7M 11.2M 5.0M 2.9M --
Change In Receivables 175,471 561,849 229,699 -195,036 --
Change In Payables And Accrued Expense 1.5M 10.6M 4.8M 3.3M --
Other Non Cash Items 523,736 -150,484 -676,335 -838,570 --
Capital Expenditure -- -- -99,259 -329,000 -17,229
Purchase Of PPE -- 0.00 -99,259 -329,000 -17,229
Net PPE Purchase And Sale 24,958 0.00 -99,259 -329,000 --
Purchase Of Investment -- 0.00 -18.1M -59.0M --
Sale Of Investment 0.00 11.1M 53.0M 13.0M --
Net Investment Purchase And Sale 0.00 11.1M 34.9M -46.0M --
Investing Cash Flow 24,958 11.1M 34.8M -46.3M --
Cash Flow From Continuing Investing Activities 24,958 11.1M 34.8M -46.3M --
Issuance Of Debt 4.9M 0.00 -- -- --
Repayment Of Debt -112,756 -169,230 -171,931 -168,560 --
Net Issuance Payments Of Debt 4.8M -169,230 -171,931 -168,560 --
Issuance Of Capital Stock 248,639 5.0M 0.00 20.3M --
Net Common Stock Issuance 248,639 5.0M 0.00 20.3M --
Financing Cash Flow 5.1M 5.1M 503,461 36.7M --
Cash Flow From Continuing Financing Activities 5.1M 5.1M 503,461 36.7M --
Changes In Cash -5.7M -2.7M 4.9M -24.1M --
Beginning Cash Position 6.0M 8.7M 3.8M 27.9M --
End Cash Position 265,004 6.0M 8.7M 3.8M --
Free Cash Flow -10.9M -18.9M -30.4M -14.8M --
Income Tax Paid Supplemental Data 9,403 0.00 0.00 0.00 --
Change In Prepaid Assets 24,157 5,494 3,348 -163,812 --
Common Stock Issuance 248,639 5.0M 0.00 20.3M --
Long Term Debt Issuance 1.2M 0.00 -- -- --
Long Term Debt Payments -112,756 -169,230 -171,931 -168,560 --
Net Income From Continuing Operations -15.7M -32.2M -39.0M -24.4M --
Net Long Term Debt Issuance 1.1M -169,230 -171,931 -168,560 --
Net Other Financing Charges 64,825 261,422 675,392 323,470 --
Net Other Investing Changes -- 35,304 -35,304 -12,312 -211,548
Net Short Term Debt Issuance 3.7M 0.00 -- -- --
Proceeds From Stock Option Exercised 0.00 15,750 0.00 16.2M --
Sale Of PPE 24,958 0.00 -- -- --
Short Term Debt Issuance 3.7M 0.00 -- -- --
NEWS
Loading news...
TRENDING
Loading...